Stroke Journal

Overview

publication venue for

• Basilar artery occlusion in a young patient with Wegener's granulomatosis. 1994
• Acute ischemic stroke from fibrocartilaginous embolism to the middle cerebral artery. 1993
• Bilateral middle cerebral artery occlusions in neurocysticercosis. 1992
• Mechanical Thrombectomy Access Score: A Systematic Review and Modified Delphi of Global Barriers to Endovascular Therapy. 2024
• Stroke Risk After Emergency Department Treat-and-Release Visit for a Fall. 2024
• Antithrombotic Treatment for Stroke Prevention in Cervical Artery Dissection: The STOP-CAD Study..  55. 2024
• Association Between Hematoma Volume and Risk of Subsequent Ischemic Stroke: A MISTIE III and ATACH-2 Analysis. 2024
• Association of Assisted Reproductive Technology and Stroke During Hospitalization for Delivery in the United States. 2024
• Antithrombotic and Statin Prescription After Intracerebral Hemorrhage in the Get With The Guidelines-Stroke Registry. 2023
• Guidelines in Action: Management of Acute and Chronic Hydrocephalus Following Aneurysmal Subarachnoid Hemorrhage. 2023
• Racial and Ethnic Differences in the Risk of Ischemic Stroke After Nontraumatic Intracerebral Hemorrhage. 2023
• Association Between Soluble Intercellular Adhesion Molecule-1 and Intracerebral Hemorrhage Outcomes in the FAST Trial. 2023
• Cost-Effectiveness of Smoking Cessation Interventions in Patients With Ischemic Stroke and Transient Ischemic Attack..  54. 2023
• Early Stroke and Mortality After Percutaneous Left Atrial Appendage Occlusion in Patients With Atrial Fibrillation..  54. 2023
• Golden Hour Treatment With tPA (Tissue-Type Plasminogen Activator) in the BEST-MSU Study..  54. 2023
• Risk of Stroke After Posterior Reversible Encephalopathy Syndrome. 2022
• Laparoscopically Confirmed Endometriosis and Risk of Incident Stroke: A Prospective Cohort Study. 2022
• Delayed Infiltration of Peripheral Monocyte Contributes to Phagocytosis and Transneuronal Degeneration in Chronic Stroke..  53. 2022
• Early Deterioration, Hematoma Expansion, and Outcomes in Deep Versus Lobar Intracerebral Hemorrhage: The FAST Trial. 2022
• Direct Oral Anticoagulants Versus Warfarin in the Treatment of Cerebral Venous Thrombosis (ACTION-CVT): A Multicenter International Study..  53. 2022
• Intraventricular Hemorrhage Expansion in the CLEAR III Trial: A Post Hoc Exploratory Analysis. 2022
• Smoking Cessation in Stroke Survivors in the United States: A Nationwide Analysis. 2021
• Stroke Among Patients Hospitalized With COVID-19: Results From the American Heart Association COVID-19 Cardiovascular Disease Registry..  53. 2021
• Biomarkers of Coagulation and Inflammation in COVID-19-Associated Ischemic Stroke..  52. 2021
• Mobile Interventional Stroke Teams Improve Outcomes in the Early Time Window for Large Vessel Occlusion Stroke..  52. 2021
• Aflibercept, a VEGF (Vascular Endothelial Growth Factor)-Trap, Reduces Vascular Permeability and Stroke-Induced Brain Swelling in Obese Mice..  52. 2021
• Reliability of Field Assessment Stroke Triage for Emergency Destination Scale Use by Paramedics: Mobile Stroke Unit First-Year Experience..  52. 2021
• Access to Mechanical Thrombectomy for Ischemic Stroke in the United States..  52. 2021
• Diffusion-Weighted Imaging Lesions After Intracerebral Hemorrhage and Risk of Stroke: A MISTIE III and ATACH-2 Analysis..  52. 2021
• Acute Cerebrovascular Events With COVID-19 Infection..  52. 2020
• Mobile Interventional Stroke Team Model Improves Early Outcomes in Large Vessel Occlusion Stroke: The NYC MIST Trial..  51. 2020
• Gastrointestinal Disorders and Risk of First-Ever Ischemic Stroke..  51. 2020
• Risk of Paradoxical Embolism (RoPE)-Estimated Attributable Fraction Correlates With the Benefit of Patent Foramen Ovale Closure: An Analysis of 3 Trials..  51. 2020
• Machine Learning Prediction of Stroke Mechanism in Embolic Strokes of Undetermined Source..  51. 2020
• Anticoagulation Type and Early Recurrence in Cardioembolic Stroke: The IAC Study..  51. 2020
• Cerebrovascular Complications of COVID-19..  51. 2020
• Impact of Multiple Social Determinants of Health on Incident Stroke..  51. 2020
• Sustained Increases in Immune Transcripts and Immune Cell Trafficking During the Recovery of Experimental Brain Ischemia..  51. 2020
• Combining Imaging and Genetics to Predict Recurrence of Anticoagulation-Associated Intracerebral Hemorrhage..  51. 2020
• Distinct Commensal Bacterial Signature in the Gut Is Associated With Acute and Long-Term Protection From Ischemic Stroke..  51. 2020
• Trends in Active Cigarette Smoking Among Stroke Survivors in the United States, 1999 to 2018..  51. 2020
• Misdiagnosis of Cervicocephalic Artery Dissection in the Emergency Department..  51. 2020
• Non-Traumatic Subdural Hemorrhage and Risk of Arterial Ischemic Events..  51. 2020
• Redefined Measure of Early Neurological Improvement Shows Treatment Benefit of Alteplase Over Placebo..  51. 2020
• Liver Fibrosis Indices and Outcomes After Primary Intracerebral Hemorrhage..  51. 2020
• Atrial Cardiopathy and Nonstenosing Large Artery Plaque in Patients With Embolic Stroke of Undetermined Source..  51. 2020
• Reclassification of Ischemic Stroke Etiological Subtypes on the Basis of High-Risk Nonstenosing Carotid Plaque..  51. 2019
• Differences in Admission Blood Pressure Among Causes of Intracerebral Hemorrhage..  51. 2019
• Risk of Arterial Ischemic Events After Intracerebral Hemorrhage..  51. 2019
• Antiplatelet Therapy After Spontaneous Intracerebral Hemorrhage and Functional Outcomes..  50. 2019
• Association Between Intravenous Thrombolysis and Anaphylaxis Among Medicare Beneficiaries With Acute Ischemic Stroke..  50. 2019
• Cancer-Related Ischemic Stroke Has a Distinct Blood mRNA Expression Profile..  50. 2019
• Corticosterone-Mediated Body Weight Loss Is an Important Catabolic Process for Poststroke Immunity and Survival..  50. 2019
• Cost-Effectiveness of Computed Tomography Angiography in Management of Tiny Unruptured Intracranial Aneurysms in the United States..  50. 2019
• Intensive Blood Pressure Reduction and Perihematomal Edema Expansion in Deep Intracerebral Hemorrhage..  50. 2019
• Left Atrial Volume Index Is Associated With Cardioembolic Stroke and Atrial Fibrillation Detection After Embolic Stroke of Undetermined Source..  50. 2019
• Atrial Fibrillation and Brain Magnetic Resonance Imaging Abnormalities..  50. 2019
• Comparative Effectiveness of Endovascular Thrombectomy in Elderly Stroke Patients..  50. 2019
• Emphysema: A Potential Risk Factor for Subarachnoid Hemorrhage and Ruptured Aortic Aneurysm.  50. 2019
• Association Between Heart Transplantation and Subsequent Risk of Stroke Among Patients With Heart Failure..  50. 2019
• National Trends in Hospitalizations for Stroke Associated With Infective Endocarditis and Opioid Use Between 1993 and 2015..  50. 2019
• Real-World Treatment Trends in Endovascular Stroke Therapy..  50. 2019
• Is the Cost-Effectiveness of Stroke Thrombolysis Affected by Proportion of Stroke Mimics?.  50. 2019
• Risk of Radiation-Induced Cancer From Computed Tomography Angiography Use in Imaging Surveillance for Unruptured Cerebral Aneurysms..  50. 2018
• Cardioembolic Stroke Risk and Recovery After Anticoagulation-Related Intracerebral Hemorrhage..  49. 2018
• Troponin Improves the Yield of Transthoracic Echocardiography in Ischemic Stroke Patients of Determined Stroke Subtype..  49. 2018
• Resting-State Functional Connectivity Magnetic Resonance Imaging and Outcome After Acute Stroke..  49. 2018
• Association Between Unruptured Intracranial Aneurysms and Downstream Stroke..  49. 2018
• Diverse Inflammatory Response After Cerebral Microbleeds Includes Coordinated Microglial Migration and Proliferation..  49. 2018
• Misdiagnosis of Cerebral Vein Thrombosis in the Emergency Department..  49. 2018
• Population-Based Assessment of the Long-Term Risk of Seizures in Survivors of Stroke..  49. 2018
• Critical Role of Flavin and Glutathione in Complex I-Mediated Bioenergetic Failure in Brain Ischemia/Reperfusion Injury..  49. 2018
• Atrial Cardiopathy and the Risk of Ischemic Stroke in the CHS (Cardiovascular Health Study)..  49. 2018
• Relationship Between Visceral Infarction and Ischemic Stroke Subtype..  49. 2018
• Modeling the Impact of Interhospital Transfer Network Design on Stroke Outcomes in a Large City..  49. 2018
• Richard Joel Traystman, PhD..  49. 2017
• Early Elevated Troponin Levels After Ischemic Stroke Suggests a Cardioembolic Source..  49. 2017
• Corneal Confocal Microscopy Detects Corneal Nerve Damage in Patients Admitted With Acute Ischemic Stroke..  48. 2017
• Safety Outcomes After Percutaneous Transcatheter Closure of Patent Foramen Ovale..  48. 2017
• Neutrophil-Lymphocyte Ratio and Perihematomal Edema Growth in Intracerebral Hemorrhage..  48. 2017
• Safety Outcomes After Thrombolysis for Acute Ischemic Stroke in Patients With Recent Stroke..  48. 2017
• Rates of Spinal Cord Infarction After Repair of Aortic Aneurysm or Dissection..  48. 2017
• Statin Adherence Is Associated With Reduced Recurrent Stroke Risk in Patients With or Without Atrial Fibrillation..  48. 2017
• Door-to-Needle Delays in Minor Stroke: A Causal Inference Approach..  48. 2017
• Psychiatric Hospitalization Increases Short-Term Risk of Stroke..  48. 2017
• Self-Reported Stroke Risk Stratification: Reasons for Geographic and Racial Differences in Stroke Study..  48. 2017
• Neuronal Death After Hemorrhagic Stroke In Vitro and In Vivo Shares Features of Ferroptosis and Necroptosis..  48. 2017
• Risk of Acute Stroke After Hospitalization for Sepsis: A Case-Crossover Study..  48. 2017
• Symptomatic Carotid Occlusion Is Frequently Associated With Microembolization..  48. 2017
• Discharge Disposition After Stroke in Patients With Liver Disease..  48. 2016
• Timing of Carotid Revascularization Procedures After Ischemic Stroke..  48. 2016
• Stroke Risk and Mortality in Patients With Ventricular Assist Devices..  47. 2016
• Aspiration Thrombectomy After Intravenous Alteplase Versus Intravenous Alteplase Alone..  47. 2016
• Where to Focus Efforts to Reduce the Black-White Disparity in Stroke Mortality: Incidence Versus Case Fatality?.  47. 2016
• Silent Brain Infarction in Patients With Asymptomatic Carotid Artery Atherosclerotic Disease..  47. 2016
• Fibroblast Growth Factor 23 Is Associated With Subclinical Cerebrovascular Damage: The Northern Manhattan Study..  47. 2016
• Risk of Stroke After the International Classification of Diseases-Ninth Revision Discharge Code Diagnosis of Hypertensive Encephalopathy..  47. 2016
• Beneficial Effects of Implementing Stroke Protocols Require Establishment of a Geographically Distinct Unit..  46. 2015
• Electrocardiographic Left Atrial Abnormality and Risk of Stroke: Northern Manhattan Study..  46. 2015
• Perihematomal Edema and Functional Outcomes in Intracerebral Hemorrhage: Influence of Hematoma Volume and Location..  46. 2015
• Hospital Readmission Rates Among Mechanically Ventilated Patients With Stroke..  46. 2015
• Clipping and Coiling of Unruptured Intracranial Aneurysms Among Medicare Beneficiaries, 2000 to 2010..  46. 2015
• Predictors of Mortality in Acute Ischemic Stroke Intervention: Analysis of the North American Solitaire Acute Stroke Registry..  46. 2015
• Early Recurrence and Cerebral Bleeding in Patients With Acute Ischemic Stroke and Atrial Fibrillation: Effect of Anticoagulation and Its Timing: The RAF Study..  46. 2015
• Systolic Blood Pressure Control and Mortality After Stroke in Hypertensive Patients..  46. 2015
• Left atrial enlargement and stroke recurrence: the Northern Manhattan Stroke Study..  46. 2015
• Predictors of finding occult atrial fibrillation after cryptogenic stroke..  46. 2015
• Association between left atrial abnormality on ECG and vascular brain injury on MRI in the Cardiovascular Health Study..  46. 2015
• Frontal networks associated with command following after hemorrhagic stroke..  46. 2014
• Influence of age on clinical and revascularization outcomes in the North American Solitaire Stent-Retriever Acute Stroke Registry..  45. 2014
• Transcranial laser therapy in acute stroke treatment: results of neurothera effectiveness and safety trial 3, a phase III clinical end point device trial..  45. 2014
• Intraventricular thrombolysis in intracerebral hemorrhage requiring ventriculostomy: a decade-long real-world experience..  45. 2014
• P-wave morphology and the risk of incident ischemic stroke in the Multi-Ethnic Study of Atherosclerosis..  45. 2014
• Cryptogenic subtype predicts reduced survival among cancer patients with ischemic stroke..  45. 2014
• Diagnostic yield of pelvic magnetic resonance venography in patients with cryptogenic stroke and patent foramen ovale..  45. 2014
• Acute cerebrovascular disease occurring after hospital discharge for labor and delivery..  45. 2014
• Stroke in patients with aortic stenosis: the Simvastatin and Ezetimibe in Aortic Stenosis study..  45. 2014
• Age-dependent neurovascular dysfunction and damage in a mouse model of cerebral amyloid angiopathy..  45. 2014
• Dichotomous effects of chronic intermittent hypoxia on focal cerebral ischemic injury..  45. 2014
• North American SOLITAIRE Stent-Retriever Acute Stroke Registry: choice of anesthesia and outcomes..  45. 2014
• Variability in outcome after elective cerebral aneurysm repair in high-volume academic medical centers..  45. 2014
• Cerebral cavernous malformations arise independent of the heart of glass receptor..  45. 2014
• Prohibitin viral gene transfer protects hippocampal CA1 neurons from ischemia and ameliorates postischemic hippocampal dysfunction..  45. 2014
• Predicting future brain tissue loss from white matter connectivity disruption in ischemic stroke..  45. 2014
• Evaluation of computed tomography angiography plaque thickness measurements in high-grade carotid artery stenosis..  45. 2014
• Transient global amnesia and the risk of ischemic stroke..  45. 2013
• Balloon guide catheter improves revascularization and clinical outcomes with the Solitaire device: analysis of the North American Solitaire Acute Stroke Registry..  45. 2013
• Dynamic permeability and quantitative susceptibility: related imaging biomarkers in cerebral cavernous malformations..  45. 2013
• THRIVE score predicts ischemic stroke outcomes and thrombolytic hemorrhage risk in VISTA..  44. 2013
• Thrombolysis for acute ischemic stroke in patients with cancer: a population study..  44. 2013
• Life's Simple 7 and risk of incident stroke: the reasons for geographic and racial differences in stroke study..  44. 2013
• Lipoprotein receptor-related protein-6 protects the brain from ischemic injury..  44. 2013
• Comparison of flow diversion and coiling in large unruptured intracranial saccular aneurysms..  44. 2013
• Hematoma volume measurement in gradient echo MRI using quantitative susceptibility mapping..  44. 2013
• Explicit consideration of baseline factors to assess recombinant tissue-type plasminogen activator response with respect to race and sex..  44. 2013
• Foot drop stimulation versus ankle foot orthosis after stroke: 30-week outcomes..  44. 2013
• Paroxysmal supraventricular tachycardia and the risk of ischemic stroke..  44. 2013
• A concerted appeal for international cooperation in preclinical stroke research..  44. 2013
• Ticagrelor in patients with acute coronary syndromes and stroke: interpretation of subgroups in clinical trials..  44. 2013
• Statins reduce neurologic injury in asymptomatic carotid endarterectomy patients..  44. 2013
• Brain and circulating levels of Aβ1-40 differentially contribute to vasomotor dysfunction in the mouse brain..  44. 2012
• Pilot randomized trial of outpatient cardiac monitoring after cryptogenic stroke..  44. 2012
• Evidence for a strong genetic influence on carotid plaque characteristics: an international twin study..  43. 2012
• Detailed analysis of periprocedural strokes in patients undergoing intracranial stenting in Stenting and Aggressive Medical Management for Preventing Recurrent Stroke in Intracranial Stenosis (SAMMPRIS)..  43. 2012
• Chronic valproate treatment enhances postischemic angiogenesis and promotes functional recovery in a rat model of ischemic stroke..  43. 2012
• Reperfusion rather than ischemia drives the formation of ubiquitin aggregates after middle cerebral artery occlusion..  43. 2012
• Application of the ABCD2 score to identify cerebrovascular causes of dizziness in the emergency department..  43. 2012
• Contrast delay on perfusion CT as a predictor of new, incident infarct: a retrospective cohort study..  43. 2012
• Cost-effectiveness of dabigatran compared with warfarin for stroke prevention in patients with atrial fibrillation and prior stroke or transient ischemic attack..  43. 2012
• Transition to collateral flow after arterial occlusion predisposes to cerebral venous steal..  43. 2012
• Accuracy of neurovascular fellows' prognostication of outcome after subarachnoid hemorrhage..  43. 2012
• The argatroban and tissue-type plasminogen activator stroke study: final results of a pilot safety study..  43. 2012
• Asymmetric pattern of cerebrovascular lesions in patients after left ventricular assist device implantation..  43. 2011
• Incremental value of biochemical and echocardiographic measures in prediction of ischemic stroke: the Strong Heart Study..  43. 2011
• The safety of intravenous thrombolysis for ischemic stroke in patients with pre-existing cerebral aneurysms: a case series and review of the literature..  43. 2011
• Statin use during ischemic stroke hospitalization is strongly associated with improved poststroke survival..  43. 2011
• Blood pressure reduction, decreased diffusion on MRI, and outcomes after intracerebral hemorrhage..  43. 2011
• Traditional risk factors as the underlying cause of racial disparities in stroke: lessons from the half-full (empty?) glass..  42. 2011
• Validation of the Stroke Prognostic Instrument-II in a large, modern, community-based cohort of ischemic stroke survivors..  42. 2011
• Self-reported stroke symptoms without a prior diagnosis of stroke or transient ischemic attack: a powerful new risk factor for stroke..  42. 2011
• Baseline and longitudinal increases in diastolic blood pressure are associated with greater white matter hyperintensity volume: the northern Manhattan study..  42. 2011
• An economic analysis of robot-assisted therapy for long-term upper-limb impairment after stroke..  42. 2011
• Severity of intraventricular extension correlates with level of admission glucose after intracerebral hemorrhage..  42. 2011
• Partial aortic occlusion and cerebral venous steal: venous effects of arterial manipulation in acute stroke..  42. 2011
• Safety of stenting and endarterectomy by symptomatic status in the Carotid Revascularization Endarterectomy Versus Stenting Trial (CREST)..  42. 2011
• Metrics for measuring quality of care in comprehensive stroke centers: detailed follow-up to Brain Attack Coalition comprehensive stroke center recommendations: a statement for healthcare professionals from the American Heart Association/American Stroke Association..  42. 2011
• Autoantibodies against the fibrinolytic receptor, annexin A2, in cerebral venous thrombosis..  42. 2010
• Brain glucose metabolism in vascular white matter disease with dementia: differentiation from Alzheimer disease..  41. 2010
• Study design of the CLOSURE I Trial: a prospective, multicenter, randomized, controlled trial to evaluate the safety and efficacy of the STARFlex septal closure system versus best medical therapy in patients with stroke or transient ischemic attack due to presumed paradoxical embolism through a patent foramen ovale..  41. 2010
• Is thrombolysis safe in the elderly?: analysis of a national database..  41. 2010
• Plasma VAP-1/SSAO activity predicts intracranial hemorrhages and adverse neurological outcome after tissue plasminogen activator treatment in stroke..  41. 2010
• Hospital mortality and complications of electively clipped or coiled unruptured intracranial aneurysm..  41. 2010
• Cost-effectiveness of outpatient cardiac monitoring to detect atrial fibrillation after ischemic stroke..  41. 2010
• Randomized, placebo-controlled, clinical trial of donepezil in vascular dementia: differential effects by hippocampal size..  41. 2010
• Key role of CD36 in Toll-like receptor 2 signaling in cerebral ischemia..  41. 2010
• Racial disparities in awareness and treatment of atrial fibrillation: the REasons for Geographic and Racial Differences in Stroke (REGARDS) study..  41. 2010
• Caregiving strain and estimated risk for stroke and coronary heart disease among spouse caregivers: differential effects by race and sex..  41. 2010
• Brain ischemic preconditioning does not require PARP-1..  41. 2009
• Blood pressure and stroke in heart failure in the REasons for Geographic And Racial Differences in Stroke (REGARDS) study..  40. 2009
• Anticonvulsant use and outcomes after intracerebral hemorrhage..  40. 2009
• Reduced platelet activity is associated with early clot growth and worse 3-month outcome after intracerebral hemorrhage..  40. 2009
• Leptin is induced in the ischemic cerebral cortex and exerts neuroprotection through NF-kappaB/c-Rel-dependent transcription..  40. 2008
• Perfusion augmentation in acute stroke using mechanical counter-pulsation-phase IIa: effect of external counterpulsation on middle cerebral artery mean flow velocity in five healthy subjects..  39. 2008
• Prevalence and correlates of subclinical atherosclerosis in Alaska Eskimos: the GOCADAN study..  39. 2008
• Mechanical thrombectomy for acute ischemic stroke: final results of the Multi MERCI trial..  39. 2008
• Overexpression of dimethylarginine dimethylaminohydrolase inhibits asymmetric dimethylarginine-induced endothelial dysfunction in the cerebral circulation..  39. 2007
• The cost of pediatric stroke care and rehabilitation..  39. 2007
• Lipopolysaccharide induces early tolerance to excitotoxicity via nitric oxide and cGMP..  38. 2007
• Stroke symptoms in individuals reporting no prior stroke or transient ischemic attack are associated with a decrease in indices of mental and physical functioning..  38. 2007
• Time-dependent alterations in functional and pharmacological arteriolar reactivity after subarachnoid hemorrhage..  38. 2007
• Site of arterial occlusion identified by transcranial Doppler predicts the response to intravenous thrombolysis for stroke..  38. 2007
• Clinical deterioration after intravenous recombinant tissue plasminogen activator treatment: a multicenter transcranial Doppler study..  38. 2006
• Postischemic augmentation of conducted dilation in cerebral arterioles..  38. 2006
• Impact of basilar artery vasospasm on outcome in patients with severe cerebral vasospasm after aneurysmal subarachnoid hemorrhage..  37. 2006
• ADMA increases arterial stiffness and decreases cerebral blood flow in humans..  37. 2006
• Telemedicine-guided carotid and transcranial ultrasound: a pilot feasibility study..  37. 2005
• Mitral annular calcification, aortic valve sclerosis, and incident stroke in adults free of clinical cardiovascular disease: the Strong Heart Study..  36. 2005
• Safety and efficacy of mechanical embolectomy in acute ischemic stroke: results of the MERCI trial..  36. 2005
• Early recanalization rates and clinical outcomes in patients with tandem internal carotid artery/middle cerebral artery occlusion and isolated middle cerebral artery occlusion..  36. 2005
• Aggressive mechanical clot disruption: a safe adjunct to thrombolytic therapy in acute stroke?.  36. 2004
• Yield and accuracy of urgent combined carotid/transcranial ultrasound testing in acute cerebral ischemia..  36. 2004
• Interaction between inducible nitric oxide synthase and poly(ADP-ribose) polymerase in focal ischemic brain injury..  35. 2004
• MERCI 1: a phase 1 study of Mechanical Embolus Removal in Cerebral Ischemia..  35. 2004
• Basilar artery vasospasm and delayed posterior circulation ischemia after aneurysmal subarachnoid hemorrhage..  35. 2004
• Impact of surgical clipping on survival in unruptured and ruptured cerebral aneurysms: a population-based study..  35. 2004
• Emerging therapies for vascular dementia and vascular cognitive impairment..  35. 2004
• Acute basilar artery occlusion: diffusion-perfusion MRI characterization of tissue salvage in patients receiving intra-arterial stroke therapies..  35. 2004
• Detection of reversed basilar flow with power-motion Doppler after acute occlusion predicts favorable outcome..  35. 2003
• Validation of computed tomographic middle cerebral artery "dot"sign: an angiographic correlation study..  34. 2003
• Efficacy and tolerability of donepezil in vascular dementia: positive results of a 24-week, multicenter, international, randomized, placebo-controlled clinical trial..  34. 2003
• Perfusion-weighted magnetic resonance imaging thresholds identifying core, irreversibly infarcted tissue..  34. 2003
• The New York Islands AVM Study: design, study progress, and initial results..  34. 2003
• Ischemic preconditioning in the hippocampus of a knockout mouse lacking SUR1-based K(ATP) channels..  34. 2003
• Contrast-enhanced magnetic resonance angiography of carotid arteries: utility in routine clinical practice..  33. 2002
• Different mechanisms of secondary neuronal damage in thalamic nuclei after focal cerebral ischemia in rats..  33. 2002
• CT angiography with whole brain perfused blood volume imaging: added clinical value in the assessment of acute stroke..  33. 2002
• Carotid stenting and endarterectomy: a clinical and cost comparison of revascularization strategies..  33. 2002
• Predictors of hemorrhagic transformation in patients receiving intra-arterial thrombolysis..  33. 2002
• Reemergence of stroke deficits with midazolam challenge..  33. 2002
• Cyclooxygenase-2 inhibitor ns-398 protects neuronal cultures from lipopolysaccharide-induced neurotoxicity..  32. 2001
• Trend of stroke hospitalization, United States, 1988-1997..  32. 2001
• A double-blind, placebo-controlled study of the use of amphetamine in the treatment of aphasia..  32. 2001
• Collateral growth and angiogenesis around cortical stroke..  32. 2001
• Utility of perfusion-weighted CT imaging in acute middle cerebral artery stroke treated with intra-arterial thrombolysis: prediction of final infarct volume and clinical outcome..  32. 2001
• Seasonal distribution of antiphospholipid antibodies..  32. 2001
• Safety of intra-arterial thrombolysis in the postoperative period..  32. 2001
• A modified transorbital baboon model of reperfused stroke..  31. 2000
• Postischemic cerebrovascular E-selectin expression mediates tissue injury in murine stroke..  31. 2000
• Dietary potassium intake and stroke mortality..  31. 2000
• Effect of hypervolemic therapy on cerebral blood flow after subarachnoid hemorrhage : a randomized controlled trial..  31. 2000
• Caspase inhibitors reduce neuronal injury after focal but not global cerebral ischemia in rats..  31. 2000
• Agreement and variability in the interpretation of early CT changes in stroke patients qualifying for intravenous rtPA therapy..  30. 1999
• Effects of moderate hypothermia on leukocyte- endothelium interaction in the rat pial microvasculature after transient middle cerebral artery occlusion..  30. 1999
• Elevated anticardiolipin antibody titer is a stroke risk factor in a multiethnic population independent of isotype or degree of positivity..  30. 1999
• The neuroprotective effect of the novel AMPA receptor antagonist PD152247 (PNQX) in temporary focal ischemia in the rat..  30. 1999
• Myocardial injury and left ventricular performance after subarachnoid hemorrhage..  30. 1999
• Estrogen provides neuroprotection in transient forebrain ischemia through perfusion-independent mechanisms in rats..  30. 1999
• Acute stroke teams: results of a national survey. National Acute Stroke Team Group..  29. 1998
• Perilesional blood flow and edema formation in acute intracerebral hemorrhage: a SPECT study..  29. 1998
• Clinical features of moyamoya disease in the United States..  29. 1998
• Activation of cerebellar climbing fibers increases cerebellar blood flow: role of glutamate receptors, nitric oxide, and cGMP..  29. 1998
• Intravenous tissue plasminogen activator for acute ischemic stroke: feasibility, safety, and efficacy in the first year of clinical practice..  29. 1998
• Intra-arterial nitrovasodilators do not increase cerebral blood flow in angiographically normal territories of arteriovenous malformation patients..  28. 1997
• Inducible nitric oxide synthase gene expression in vascular cells after transient focal cerebral ischemia..  27. 1996
• Aminoguanidine ameliorates and L-arginine worsens brain damage from intraluminal middle cerebral artery occlusion..  27. 1996
• Comparison of transcranial Doppler ultrasonography and transesophageal echocardiography to monitor emboli during coronary artery bypass surgery..  27. 1996
• Glutamate-induced cerebral vasodilation is mediated by nitric oxide through N-methyl-D-aspartate receptors..  26. 1995
• Cerebral emboli detected during bypass surgery are associated with clamp removal..  25. 1994
• Evaluation of delayed treatment of focal cerebral ischemia with three selective kappa-opioid agonists in cats..  25. 1994
• Antioxidants attenuate microvascular changes in the early phase of experimental pneumococcal meningitis in rats..  23. 1992
• Risk factors for white matter changes detected by magnetic resonance imaging in the elderly..  21. 1990
• Use of diastolic velocity ratios to predict significant carotid artery stenosis..  19. 1988
• Early component changes in corticomotor evoked potentials following experimental stroke..  18. 1987
• Transient ischemic attacks associated with hypotension in hypertensive patients with carotid artery stenosis..  12. 1981
• Fibromuscular disease of carotid arteries: long term results of graduated internal dilatation..  12. 1981
• Improved results of carotid endarterectomy in patients with symptomatic coronary disease: an analysis of 1,546 consecutive carotid operations..  10. 1979
• Cerebrovascular regulation in preganglionic and postganglionic autonomic insufficiency..  4. 1973
• Response by Liberman et al to Letter Regarding Article, "Misdiagnosis of Cerebral Vein Thrombosis in the Emergency Department"..  49. 2018
• Response by Merkler et al to Letter Regarding Article, "Safety Outcomes After Percutaneous Transcatheter Closure of Patent Foramen Ovale"..  49. 2017
• Response by Murthy et al to Letter Regarding Article, "Restarting Anticoagulant Therapy After Intracranial Hemorrhage: A Systematic Review and Meta-Analysis"..  48. 2017
• Response by Merkler et al to Letter Regarding Article, "Risk of Pulmonary Embolism After Cerebral Venous Thrombosis"..  48. 2017
• Response by Parikh and Kamel to Letter Regarding Article, "Stroke Risk and Mortality in Patients With Ventricular Assist Devices"..  48. 2016
• Anticoagulation intensity and stroke during warfarin-use in atrial fibrillation patients..  37. 2006
• Hypertension, angiotensin, and stroke: beyond blood pressure..  35. 2004
• Converging pathogenic mechanisms in vascular and neurodegenerative dementia..  34. 2003
• Ischemic strokes arriving too late for tPA are an ideal and ethical control group for continuing studies of tPA efficacy..  29. 1998
• Rheological behavior of white blood cells..  20. 1989
• Significance of age-related white matter lesions..  19. 1988
• Influenza-Like Illness as a Short-Term Risk Factor for Arterial Dissection. 2023
• Smoking-Cessation Pharmacotherapy After Stroke and Transient Ischemic Attack: A Get With The Guidelines-Stroke Analysis. 2023
• Association Between Systemic Amyloidosis and Intracranial Hemorrhage. 2022
• International Study of Intracranial Aneurysm Treatment Using Woven EndoBridge: Results of the WorldWideWEB Consortium. 2021
• Response by Salehi Omran and Kamel to Letter Regarding Article, "National Trends in Hospitalizations for Stroke Associated With Infective Endocarditis and Opioid Use Between 1993 and 2015". 2019
• Letter by Liberman et al Regarding Article, "Psychiatric Hospitalization Increases Short-Term Risk of Stroke". 2017
• Response to letter regarding article, "Ticagrelor in patients with acute coronary syndromes and stroke: interpretation of subgroups in clinical trials". 2013
• Proceedings of Recent Developments and Future Directions in Stroke Management and Prevention symposium: preface. 2010
• Genetics and the Quest to Define Sources of Cardiac Embolism..  54. 2023
• Chronic Kidney Disease and Stroke Outcomes: Beyond Serum Creatinine..  54. 2023
• Guidelines for the Early Management of Patients With Acute Ischemic Stroke: 2019 Update to the 2018 Guidelines for the Early Management of Acute Ischemic Stroke..  50. 2019
• Prehospital Phase of Acute Stroke Care: Guideline and Policy Considerations as Science and Evidence Rapidly Evolve..  50. 2019
• Tracking down atrial fibrillation in the stroke unit..  43. 2012
• From UBOs to Binswanger's disease. Impact of magnetic resonance imaging on vascular dementia research..  27. 1996
• Concern about safety of carotid angioplasty..  27. 1996
• Jump Starting Your Clinical Research Career Using Administrative Data Sets for Stroke Research. 2018
• Defining Optimal Brain Health in Adults: A Presidential Advisory From the American Heart Association/American Stroke Association. 2017
• Genome-wide association studies of intracranial aneurysms: an update. 2013
• Statin therapy and outcome after ischemic stroke: systematic review and meta-analysis of observational studies and randomized trials. 2013
• Stroke: working toward a prioritized world agenda. 2010
• Biology of vascular malformations of the brain. 2009
• The Janus face of cyclooxygenase-2 in ischemic stroke: shifting toward downstream targets. 2005
• Subarachnoid Hemorrhage Trials: Cutting, Sliding, or Keeping mRS Scores and WFNS Grades. 2024
• Patent Foramen Ovale Management for Secondary Stroke Prevention: State-of-the-Art Appraisal of Current Evidence. 2023
• Most Promising Approaches to Improve Stroke Outcomes: The Stroke Treatment Academic Industry Roundtable XII Workshop. 2023
• Enhancing Enrollment in Acute Stroke Trials: Current State and Consensus Recommendations. 2023
• Management of Stroke in Patients With Chronic Liver Disease: A Practical Review. 2023
• The Neurovasculome: Key Roles in Brain Health and Cognitive Impairment: A Scientific Statement From the American Heart Association/American Stroke Association. 2023
• Cardiovascular Events After Intracerebral Hemorrhage. 2022
• Mobile Stroke Units: Evidence, Gaps, and Next Steps. 2022
• 2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline From the American Heart Association/American Stroke Association. 2021
• Thrombophilia Testing After Ischemic Stroke: Why, When, and What? 2021
• Cancer and Embolic Stroke of Undetermined Source. 2021
• What Do Experimental Models Teach Us About Comorbidities in Stroke? 2018
• Stratifying Stroke Risk in Atrial Fibrillation: Beyond Clinical Risk Scores. 2017
• P-Wave Indices and Risk of Ischemic Stroke: A Systematic Review and Meta-Analysis. 2017
• Global Stroke Belt: Geographic Variation in Stroke Burden Worldwide. 2015
• Cerebrovascular reserve and stroke risk in patients with carotid stenosis or occlusion: a systematic review and meta-analysis. 2012
• Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the american heart association/american stroke association. 2011
• Citicoline in vascular cognitive impairment and vascular dementia after stroke. 2010
• Statin use and sex-specific stroke outcomes in patients with vascular disease. 2006

Identity

ISO Abbreviation

• Stroke

Linking ISSN

• 0039-2499

International Standard Serial Number (ISSN)

• 0039-2499

Electronic International Standard Serial Number (EISSN)

• 1524-4628